Home01_Welcome_to_KDH.html01_Welcome_to_KDH.htmlshapeimage_3_link_0
Technology031_Technology.html031_Technology.htmlshapeimage_4_link_0
Investors04_Investors.html04_Investors.htmlshapeimage_5_link_0
News & Events051_News_%26_Events.html051_News_%26_Events.htmlshapeimage_6_link_0
Contact Us014_Contact_Us.html014_Contact_Us.htmlshapeimage_7_link_0

BENEFITS

Benefitsshapeimage_9_link_0
GHN Deployment023_Deployments.html023_Deployments.htmlshapeimage_10_link_0

Clinical Trial Managers and Principal Investigators

More products Earlier market entry
PHARMA, BIOTECH, DEVICE MAKERS
More effective treatments Lower health-care costs
SOCIETY
More research opportunities Better therapies
PHYSICIANS
New or additional revenue Better patient care
HOSPITALS
Better data Audit trail to relevant records
FDA
Better quality of life Opportunities for life-saving research
PATIENTS

  1. ‣The GHN provides more viable trial candidates at lowers cost and in less time.

  2. ‣The GHN provides the PI an opportunity to enroll a patient before or during treatment.

  3. ‣In person patient enrollment opportunities during acute phase treatments significantly reduces failure to enroll.

Our Company011_Introduction_to_KDH.html011_Introduction_to_KDH.htmlshapeimage_30_link_0
Solutions021_Solutions.html021_Solutions.htmlshapeimage_31_link_0
Solutions Overview021_Solutions.html021_Solutions.htmlshapeimage_32_link_0

CLINICAL PATIENT RECRUITMENT SOLUTIONS

FOR THE 21st CENTURY

CLIENT LOGIN >>08_Client_Login.html08_Client_Login.htmlshapeimage_33_link_0

400 million

hospital patient visits annually in the U.S.

Contact Us014_Contact_Us.html014_Contact_Us.htmlshapeimage_35_link_0

The KDH Global Health Network is unique because it provides direct benefits to patients, clinical trial managers, principal investigators as well as the hospital or clinic sites that host the network.

SIGNIFICANT BENEFITS FOR ALL STAKEHOLDERS

PHARMA, BIOTECH AND MEDICAL DEVICE MANUFACTURERS

  1. ‣Reduced clinical trial times results in more time in market under patent for new treatments.

  2. ‣Ability to get to earlier GO/NO GO decisions during clinical trials.

  3. ‣Reduced cost and time to complete enrollment requirements for clinical trials.

  4. ‣The GHN provides significant productivity enhancements for the entire clinical trial process.

PATIENTS AND SOCIETY

  1. ‣Having new treatments available in the market sooner results in more effective treatments and better treatment outcomes ultimately resulting in lower health care costs.

Hospitals, Clinics and Urgent Care Facilities - Worldwide

  1. ‣Participating hospitals, clinics or urgent care facilities incurs no significant cost for joining the GHN.

  2. ‣Participating GHN sites are able to increase their revenues through increased access to clinical trials and the increased opportunities for patient care during the trails

  3. ‣Providing treating physicians with additional treatment options results in better patient outcomes.

  4. ‣Investigators pay for access. Delivers increased earnings for hospitals and investigators.

REGULATORY AGENCIES

  1. ‣The GHN provides a clear and unbroken audit trail of patient recruiting activities.

  2. ‣The GHN provides better data capture since is automatically tracks all aspects of the recruiting process.

Physicians

  1. ‣Provides treating physicians with additional treatment options, resulting in better patient outcomes.

  2. ‣Physicians have access to and are able to participate in more research opportunities.